Regeneron And Zai Lab Announce Regional Strategic Collaboration For REGN1979 (CD20xCD3 Bispecific Antibody); Regeneron To Receive $30M Upfront, Eligible To Receive Up To $160M In Additional Milestones
Benzinga Newsdesk